Interaction of Coronavirus Disease 2019 with other Infectious and Systemic Diseases

ISBN-13: 9781032350165 / Angielski

M. Tabish Qidwai

Opis

The book "Interaction of Coronavirus Disease 2019 with other Infectious and Systemic Diseases" elaborates on the pathogenesis, co-infection, and association of COVID-19 with other Infectious and Systemic Diseases. Moreover, this book explains pharmacological interventions, and therapeutic targets in COVID19. All chapters cover the different aspects of COVID-19. This book gives first-hand information on the co-infection, post-COVID effects, nanomedicine, and pharmacogenomics in COVID-19.

The book offers comprehensive coverage of the most essential topics, including:

• Recent developments in COVID-19 pathogenesis and treatment
• Association of COVID-19 with Infectious diseases and Systemic Diseases
• COVID-19 and Co-infection
• Post-COVID and long-term COVID problems
• Nanomedicine and pharmacogenomics in COVID-19

　

While other books may touch on COVID-19 pathophysiology and treatment strategies. Unique aspect of this book is that it covers post COVID effects, and Interaction of Coronavirus Disease 2019 with other Infectious and Systemic Diseases.

Spis treści

Part I: Current Trends in Pathophysiology and Post COVID Effects. 1. Pathophysiology of SARS-CoV-2 Tejal Shreeya, Tabish Qidwai, and Bhartendu Nath Mishra. 2. Investigation of Post COVID/Long COVID Complications in Humans Sukanya Tripathy, Sanjay Singh, Monisha Banerjee, and Anand Prakash. PART II: Sars Co-V2 Co-Infection with other Pathogens. 3. Falciparum malaria and COVID-19 co-infections AashnaSrivastava, Tabish Qidwai, and Mariam Imam . 4. Interaction of COVID-19 and Tuberculosis  Malti Dadheech and Anand Kumar Maurya. 5. Co-Infection of SARS-CoV-2 with Viruses Causing Respiratory and Systemic Infections Sabiha Fatima^, Samina Wasi, Nikhat Jamal Siddiqi, and Reem Hamoud Alrashoudi. Part III: Covid-19 and Neurological Complications. 6. Neurological Association of COVID-19 and Neurodegenerative Disorders Shilpa Kumari, Ankit Madeshiya, and Sarika Singh. PART IV: COVID-19 and Cancer. 7. Impact of COVID-19 on Cancer Care, Prognosis, and Immuno-Oncological Challenge of COVID-19 Atar Singh Kushwah, Shireen Masood, Amreen Shamsad, and Monisha Banerjee. 8. Investigating the Severity of COVID-19 in Lung Cancer Patients and Current Treatment: Evidence and Challenges Saurabh Kumar, Osaid Masood, Shama Parveen, Sanjay Saini, and Monisha Banerjee. Part V: Current Therapeutic Approaches. 9. COVID-19 Therapy: Molecular Mechanisms, Pharmacological Interventions, and Therapeutic Targets Ruchi Chawla, Mohini Mishra, Krishan Kumar, and Varsha Rani. 10. Exploration of Nanotherapeutics in COVID-19 Nikhat J. Siddiqi, Sabiha Fathima, Sooad K. AlDaihan, Hanan A. Balto, and Bechan Sharma. 11. Pharmacogenomics and COVID-19 Rishabh Chaudhary, Divya Chaudhary, and Vikas Mishra.

O autorze

M. Tabish Qidwai is M. Tech and PhD graduate of the Biotechnology Engineering at the Dr. A.P.J. Abdul Kalam Technical University Lucknow, India, and an Associate Professor in the SRM University, UP, India. He previously worked as officiating Director of IBST, SRM University, Assistant Professor at BB Ambedkar University, Lucknow. He is working in the area of infectious disease since more than one decade. He is working as section editor of Current Indian Science (Bentham Science). He has been awarded with several prestigious awards and appreciation letters.